Grail Funding & Investors
Menlo Park, CA
GRAIL, Inc. operates as a biotechnology company. The Company focuses on combining science, technology, and clinical studies to reveal cancer at its beginings. GRAIL offers its services in the United States.
https://grail.comGrail Funding Rounds
Post Ipo Equity
$325,000,000
Post Ipo Equity Investors
hims & hersDeep Track CapitalFarallon Capital ManagementBraidwellPost Ipo Equity
$110,000,000
Post Ipo Equity Investors
Samsung C&TSamsung ElectronicsIPO
Unknown
Series D
$390,000,000
Series D Investors
PSP InvestmentsCPP Investment BoardIlluminaHuangpu River CapitalSeries C
$300,000,000
Series C Investors
6 Dimensions CapitalAlly Bridge GroupHillhouse InvestmentHuangpu River CapitalICBC InternationalHSGBlue Pool CapitalGenuity ScienceChina Merchants SecuritiesSeries B
$1,214,655,040
Series B Investors
Arch Venture PartnersJohnson & Johnson DevelopmentGlen KacherAmino CapitalThe Mark Foundation for Cancer ResearchSeries A
$100,000,000
Series A Investors
IlluminaArch Venture PartnersBezos ExpeditionsBill GatesSutter Hill VenturesBiomatics Capital PartnersGVLongwood Fund
Funding info provided by Diffbot.